Cargando…

Cytokine adsorption and ECMO in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Rybalko, Andrey, Voronin, Alexander V, Karpun, Nikolai A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260102/ https://www.ncbi.nlm.nih.gov/pubmed/34242579 http://dx.doi.org/10.1016/S2213-2600(21)00276-9

Ejemplares similares

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19
por: Bleakley, Caroline, et al.
Publicado: (2020)

ECMO support for COVID-19: a balancing act
por: Zhang, Yang, et al.
Publicado: (2021)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

ECMO and CRRT “All in One!” in COVID-19 Era
por: Condello, Ignazio, et al.
Publicado: (2023)

Etiology and Management of Bleeding during ECMO in a COVID-19 Patient
por: Yamada, Shinya, et al.
Publicado: (2021)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO
por: Guervilly, Christophe, et al.
Publicado: (2023)

Blood transfusion strategies and ECMO during the COVID-19 pandemic
por: Koeckerling, David, et al.
Publicado: (2020)

The need to define “who” rather than “if” for ECMO in COVID-19
por: Whebell, Stephen, et al.
Publicado: (2022)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO – Authors' reply
por: Lorusso, Roberto, et al.
Publicado: (2023)

ECMO support for COVID-19: a balancing act – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2021)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

Thrombolysis for ECMO oxygenator thrombosis
por: Taccone, Fabio Silvio, et al.
Publicado: (2023)

Case Report: Successful Use of Extracorporeal Therapies After ECMO Resuscitation in a Pediatric Kidney Transplant Recipient
por: Rybalko, Andrey, et al.
Publicado: (2020)

Myocardial infarction due to malposition of ECMO cannula
por: Reis Miranda, Dinis, et al.
Publicado: (2012)

Improved Strategies for ECMO in the Setting of Renal Failure
por: Jacobs, Jeffrey Phillip, et al.
Publicado: (2023)

Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: “perceived futility” and potential underestimation of ECMO’s effect
por: Watanabe, Atsuyuki
Publicado: (2022)

Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori
Publicado: (2023)

Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO
por: Levy, Yael, et al.
Publicado: (2022)

Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service
por: Camporota, Luigi, et al.
Publicado: (2021)

Postcardiotomy VA ECMO in adult patients: Italian single center experience in 2021
por: L’Acqua, Camilla, et al.
Publicado: (2022)

Prevention of the cytokine storm in COVID-19
por: Wright, David J M
Publicado: (2021)

Magnetic levitation pumps for cell-free hemoglobin prevention during VV ECMO
por: Condello, Ignazio
Publicado: (2022)

The impact of specific cytokine directed treatment on severe COVID-19
por: Reuken, P. A., et al.
Publicado: (2021)

Proposed use of thalidomide for the cytokine storm of COVID-19
por: Goihman-Yahr, Mauricio
Publicado: (2020)

Pulmonary consolidation alters the ultrasound estimate of pleural fluid volume when considering chest drainage in patients on ECMO
por: Balik, Martin, et al.
Publicado: (2022)

Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption
por: Lebreton, Guillaume, et al.
Publicado: (2021)

Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure
por: Damiani, Marianna, et al.
Publicado: (2021)

COVID-19 cytokine storm: the interplay between inflammation and coagulation
por: Jose, Ricardo J, et al.
Publicado: (2020)

Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19
por: Eldanasory, Omar Abdelhay, et al.
Publicado: (2020)

COVID-19, haemophagocytic lymphohistiocytosis, and infection-induced cytokine storm syndromes
por: Spaner, Caroline, et al.
Publicado: (2022)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
por: Winiszewski, Hadrien, et al.
Publicado: (2022)

Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
por: Sharun, Khan, et al.
Publicado: (2020)

Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
por: Cure, Erkan, et al.
Publicado: (2020)

Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome
por: Moyon, Quentin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhto0d6c578n08o0dqd7e7spba